Find new therapeutic approach to halt or to cure muscle atrophy are our main objectives regardless of etiology.
«Usually that's useless because they are already inactive in that state, but this finding suggests we might be able to
find new therapeutic approaches to target these diseases.»
We are now using these technics starting from patient - derived PSC to increase our understanding and try to
find new therapeutic approaches for devastating neurodevelopmental disorders.
Not exact matches
The study also reinforces the potential value of brain scans for identifying and understanding schizophrenia in individual patients, for
finding promising
new therapeutic approaches, and for helping clinicians track a patient's progress during therapy.
This study could open up the possibility of
finding ways to turn this activity on and off, making way for
new therapeutic approaches for hard - to - treat diseases, Wu said.
The
findings by a team of Massachusetts General Hospital (MGH) investigators, which will be published in the April 24 issue of Cell and are receiving advance online release, support the importance of epigenetics — processes controlling whether or not genes are expressed — in cancer pathology and identify molecular circuits that may be targeted by
new therapeutic approaches.
Clinical trials will be required to establish whether these promising
findings will translate into a
new therapeutic approach for ALL.
«Against the background of these
findings, we can, for example identify possible risk groups and develop
new therapeutic approaches,» adds Dr. Christian Gieger (HMGU).
Traditional
therapeutic approaches often encourage depressed patients to participate in enjoyable situations, yet the
new findings suggest that some people may first need to practice allowing themselves to feel any pleasant emotions at all.
«We
found that a specific cellular pathway, AMPK - PGC1a, likely plays a key role to reduce mitochondrial function and content, which means that
new therapeutic approaches that restore and increase mitochondrial function and content could ameliorate or perhaps even arrest chronic kidney disease.»
The Helmholtz Zentrum München aims to make basic research
findings available quickly for clinical application as well as to develop
new approaches to diagnostic and
therapeutic procedures and prevention.
Interestingly, genomic analyses suggested that ESCC and head and neck squamous cell carcinoma (HNSCC) shared some common pathogenic mechanisms, and ESCC development is associated with alcohol drinking.These
findings would provide a brand -
new insight into the understandings of ESCC tumorigenesis, and would help clinicians to develop more effective diagnostic and
therapeutic approaches for ESCC.
These
findings would provide a brand -
new insight into the understandings of ESCC tumorigenesis, and would help clinicians to develop more effective diagnostic and
therapeutic approaches for ESCC.
These
findings could help to develope
new therapeutic approaches towards genetic diseases.
The conference aims at bringing together international experts from different fields of cancer research to present and discuss
new therapeutic approaches regarding different tumor entities as well as
new findings in the field of tumor biology seeking to incorporate innovative platforms into cancer research.
These promised to provide a
new therapeutic target for treating obesity, with the researchers
finding that they share the fat - burning abilities of brown cells, though they do decrease in number as we
approach middle age.
Their
findings have redefined our understanding of how glaucoma steals sight and created possibilities for
new therapeutic approaches to the disease.
Information gained from this work will serve to enhance the clinical usefulness of
findings from genomic sequencing (for example, next - generation sequencing or comprehensive genomic profiling), determine
therapeutic approaches based on genomic
findings, aid in the development of clinical trials and related options, and provide supportive rationale for exploring
new therapies.
Currently, Vogelstein is focusing on
new, minimally invasive techniques for the early diagnosis of cancer based on his previous
findings, and
therapeutic approaches that apply what researchers now know about cancer biology.
Our
findings shed
new light on the molecular mechanisms through which LA induces antiproliferative and pro-apoptotic responses in both breast and endometrial cancer cells toward its usefulness in more comprehensive
therapeutic approaches.